JANET HAYMORE: Open Payments
NPI 1396141636 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 29 payments from 8 companies in 2025. Trend: 2023 $201 · 2024 $669 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $219 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $144 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Dexcom, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: CAPLYTA, Rybelsus, Ozempic, Wegovy, SHINGRIX, GEMTESA, Dexcom G6 Transmitter, PAXLOVID.
Industry payments across TN — which companies pay providers there.
